𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term immunosuppressive treatment of a child with Takayasu's arteritis and high IgE immunoglobulins

✍ Scribed by Michèle G. Brunette; Yvette Bonny; Linda Spigelblatt; Gaétan Barrette

Publisher
Springer
Year
1996
Tongue
English
Weight
603 KB
Volume
10
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of recurrent hemoptysis in a c
Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid
✍ L.T.K. Wong; Y.P. Liliquist; G. Culham; B.P. DeJong; A.G.F. Davidson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

The course of a 12-year-old girl with cystic fibrosis (CF) and with recurrent hemoptysis since age 8 years is described. Conservative measures failed to control her bleeding. Hemoptysis was only partially controlled by repeated bronchial arterial embolizations. However, the addition of tranexamic ac

Long-term survival of a patient with lep
Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate
✍ Carole Fakhry; Gopal Bajaj; Nafi Aygun; William Westra; Maura Gillison 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

## Abstract ## Background. Nasopharyngeal carcinoma with leptomeningeal involvement is rare and typically has poor prognosis. ## Methods and Results. We present a case report of a patient with nasopharyngeal carcinoma who was treated with high‐dose intravenous methotrexate and remains asymptomat

Long-term follow-up of a phase I study o
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
✍ Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with high‐ris